We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Halma plc (HLMA) Ordinary 10p

Sell:2,716.00p Buy:2,718.00p 0 Change: 8.00p (0.29%)
FTSE 100:0.26%
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:2,716.00p
Buy:2,718.00p
Change: 8.00p (0.29%)
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
Sell:2,716.00p
Buy:2,718.00p
Change: 8.00p (0.29%)
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Ex-dividend
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

HL comment (21 November 2024)

No recommendation - No news or research item is a personal recommendation to deal. All investments can fall as well as rise in value so you could get back less than you invest.

Halma reported a 13% rise in first-half revenue to £1.1bn. That reflected an 11.5% rise in organic revenue, excluding currency impacts. There was double-digit growth in the Safety and Environmental & Analysis sectors, with a marginal increase in Healthcare.

Underlying operating profit rose 14.8% to £222.5mn, driven by top-line growth and improving margins.

So far this year, seven acquisitions have been made, four in the first half and three since the end of the period, for a cost of around £158mn. Free cash flow rose from £135.4mn to £170.8mn. Net debt, including leases, fell 1.0% to £646.7mn since the start of the period.

Full-year guidance is unchanged, pointing to “good” organic revenue growth and an underlying operating margin of around 21%, in the middle of its target range.

The Board has declared an increase of 7% in the interim dividend to 9.00p per share.

The shares rose 9.7% in early trading.

Our view

Halma’s attraction is simple. It’s a mash-up of businesses working to provide technology solutions in the safety, health, and environmental markets. These may not be the most exciting businesses, but Halma’s clear purpose and quality of execution mean performance has been impressive.

First-half trading was strong, and margin improvements in the key safety unit have the potential to be sticky, likely a reason why markets gave a nod of approval on the day. Though not all business lines are firing on all cylinders, and that’s kind of what Halma does well - consistent delivery in the face of varied economic climates.

This differentiated business model, geared toward non-discretionary and sustainability-related demand, offers exposure to some resilient long-term growth drivers. These include increasing demand for healthcare, tighter safety regulations, and growing global efforts to address climate change, waste and pollution.

Halma has shown itself to be a safe pair of hands, last year marking its 21st consecutive year of record profit. This provides some comfort that it can prosper even in a challenging economic environment. But there are no guarantees and not all its markets are in great shape. Healthcare being a prime example where budget constraints are keeping a lid on customer orders.

Acquisitions are key to the strategy, so cash conversion (the level of operating profit backed up by cash) is essential, and Halma continued its strong history of cash generation into the first half of the current year. One of the first things we look at in a buy-and-build business model is its ability to throw off cash flow. Buying businesses isn't cheap; it's much more sustainable if it can be funded by internally generated cash.

With £85mn committed to acquisitions over the first half, this is slightly above the relatively low levels seen over the same period last year. There’s already been a flurry of activity in the early parts of the second half, which is promising to see. We don’t want Halma to buy for the sake of it, but having a healthy pipeline of deals and being able to execute is key.

The balance sheet looks in good shape and with net debt at 1.27 times cash profit, plus strong cash flow, there's plenty of room for investment should the right opportunities arise.

All in, we're supportive of Halma's business model and growth drivers. But we aren't alone, and while the valuation has come down from its pandemic highs, it's still at the top of its peer group. There's plenty of pressure to deliver.

Environmental, social and governance (ESG) risk

General Industrial companies are medium risk in terms of ESG but can trend up to the higher end of the spectrum depending on subindustry. The primary risks can include labour relations, emissions (either product or production-based), business ethics and product governance. Other concerns are waste and health & safety.

According to Sustainalytics, Halma’s management of material ESG issues is strong

Halma has appointed a dedicated management committee to oversee these areas and implemented a strong environmental policy. While its ESG reporting doesn't fully align with leading standards yet, there is a clear link between executive pay and sustainability goals. Additionally, Halma has a robust whistleblower program in place to ensure accountability.

Halma key facts

  • Forward price/earnings ratio (next 12 months): 26.7

  • Ten year average forward price/earnings ratio: 29.5

  • Prospective dividend yield (next 12 months): 1.0%

  • Ten year average prospective dividend yield: 1.1%

All ratios are sourced from Refinitiv, based on previous day’s closing values. Please remember yields are variable and not a reliable indicator of future income. Keep in mind key figures shouldn’t be looked at on their own – it’s important to understand the big picture.

This article is original Hargreaves Lansdown content, published by Hargreaves Lansdown. It was correct as at the date of publication, and our views may have changed since then. Unless otherwise stated estimates, including prospective yields, are a consensus of analyst forecasts provided by Refinitiv. These estimates are not a reliable indicator of future performance. Yields are variable and not guaranteed. Investments rise and fall in value so investors could make a loss.

This article is not advice or a recommendation to buy, sell or hold any investment. No view is given on the present or future value or price of any investment, and investors should form their own view on any proposed investment. This article has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is considered a marketing communication. Non-independent research is not subject to FCA rules prohibiting dealing ahead of research, however HL has put controls in place (including dealing restrictions, physical and information barriers) to manage potential conflicts of interest presented by such dealing. Please see our full non-independent research disclosure for more information.


Previous Halma plc updates

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.